We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

4basebio plc (4BB) ORD EUR1

Sell:1,250.00p Buy:1,350.00p 0 Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,250.00p
Buy:1,350.00p
Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:1,250.00p
Buy:1,350.00p
Change: No change
Market closed Prices as at close on 22 November 2024 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

4basebio PLC is a United Kingdom-based biotechnology company. The Company is focused on life sciences and in particular the development of synthetic Deoxyribonucleic acid (DNA) and nanoparticles suitable for inclusion in, or delivery of, therapeutic payloads for cell and gene therapies and vaccines. It is engaged in the development of advanced therapy medicinal products (ATMPs) through its high performant synthetic DNA products and non-viral, cell targeting nucleic acid delivery platform. It is engaged in the manufacturing and supplying of application specific synthetic DNA for research, therapeutic and pharmacological use and develop non-viral vectors for the efficient delivery of payloads in patients. It has technology in the fields of DNA synthesis and payload delivery, which enables it to manufacture both synthetic DNA constructs and messenger ribonucleic acid (mRNA) and develop vectors for cell and tissue-specific delivery for a range of applications.

Contact details

Address:
25 Norman Way, Over
CAMBRIDGE
CB24 5QE
United Kingdom
Telephone:
+44 (01223) 967943
Website:
https://www.4basebio.com/

Important dates

Future events
There are no future events available.
Past events
Interim results 27 September 2024 27/09/24
AGM 28 June 2024 28/06/24
Annual report 05 June 2024 05/06/24

General stock information

EPIC:
4BB
ISIN:
GB00BMCLYF79
Market cap:
£201.21 million
Shares in issue:
15.48 million
Sector:
No specific Industry
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel


Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.